AstraZeneca

This year’s World Health Assembly underscores the urgent need to transform healthcare. Global action and partnerships to prioritise and implement effective policies and interventions are crucial. Looking ahead to the UN High Level Meeting on NCDs in September, coordinated action on chronic and rare diseases has never been more vital. Now is the time to act, together, to meet the health needs of today and tomorrow. #WHA78 #Sustainability #HealthEquity #NCDs #RareDisease

#News As proud members of a Swedish business consortium, we’re pleased to share plans to establish an AI factory in collaboration with NVIDIA. Together with Ericsson, Saab, SEB, and Wallenberg Investments AB, NVIDIA’s first AI Technology Centre in Sweden will use cutting-edge AI infrastructure to accelerate drug discovery. This centre will be a global benchmark for AI innovation, setting new standards in secure and sovereign AI solutions. It marks an unprecedented opportunity to accelerate healthcare breakthroughs and underscores our commitment to leveraging AI for transformative global health solutions. Read the full news: https://learn.az/6049Nx2GW #WhatScienceCanDo

This week we joined industry peers at the Gartner Supply Chain Symposium in Barcelona, where our very own Ulrika Henningsson ♦️, Head of Manufacturing Technology Strategy, shared our ambition to transform patient value through continuous manufacturing – one of the many ways we’re leveraging AI and digital technologies to deliver medicines to patients around the world with speed, quality, and precision. #GartnerSC

While bladder cancer is the ninth most common cancer in the world, awareness remains low. May is Bladder Cancer Awareness Month and we’re proud to support the World Bladder Cancer Patient Coalition (WBCPC) in raising awareness and encouraging early detection. This year’s theme underscores the importance of recognising the early signs of bladder cancer, as the disease has an overall 78% 5-year relative survival rate. Alex Filicevas, Executive Director of the WBCPC, shares why greater awareness of symptoms can help patients receive an earlier diagnosis. #BladderCancerMonth25

🎙️ Estrenamos nuestro Recording Studio con Pascal Soriot y Rodrigo Pacheco 🎉 En AstraZeneca México, seguimos apostando por la innovación. Por ello, inauguramos un estudio de grabación para podcasts en nuestras nuevas oficinas, el cual es un espacio para generar contenidos que impulsen la colaboración y el diálogo en diferentes temas como salud, innovación, inclusión y diversidad, entre otros.  🚀 Durante la visita del Senior Executive Team (SET) en febrero, tuvimos la oportunidad de inaugurar el estudio junto a nuestro CEO global, Pascal Soriot, en una entrevista especial con el periodista Rodrigo Pacheco García del podcast RodCast. 🗣️💡 La conversación tocó temas emocionantes como: -Unir a nuestros equipos alrededor del mundo 🌍 -Celebrar los increíbles logros del 2024 y nuestras inversiones estratégicas en áreas clave 🔍 -Liderazgo en innovación para transformar vidas de millones de pacientes 🌟 ¡No te pierdas este podcast y descubre cómo estamos marcando la diferencia! 📢🎧 https://lnkd.in/eSVKx8ft #AstraZenecaMéxico #LosMejoresLugaresparaTrabajarParaMujeresenMéxico2025 #GPTW #OrgulloAZ

80% of rare diseases are associated with underlying genetic causes. Gene therapies have the potential to treat the underlying cause of many rare diseases. Our scientists are refining gene editing tools to expand their reach, improve their precision and unlock their potential in clinical applications. Learn more: https://learn.az/6048NcB48 #WhatScienceCanDo

'For investors and media' We have announced the successful completion of our acquisition of EsoBiotec, who are pioneering in vivo cell therapies. This acquisition is another step forward in our ambition to harness the full potential of cell therapy. EsoBiotec’s in vivo cell therapy platform has the potential to transform cell therapy. It aims to enable the administration of therapies in minutes through a simple IV injection—without the need for immune cell depletion. This innovative approach has the potential to streamline processes and reduce manufacturing timelines, as well as increase accessibility for patients. #AstraZenecaBusinessNews #Investors #Media

Don't miss your chance to join AstraZeneca's Project iDEA and bring your innovative solutions to life, tackling public health challenges. Whether you go solo or team up with up to four people, you'll gain access to fantastic development opportunities! 📅 Hurry! Registration closes on 23 May 2025. For more details, scan the QR code or reach out to us at [email protected]. #AstraZeneca #ProjectiDEA #Innovation #Healthcare #Students

By 2030, half of the world’s adult population could be living with #obesity or overweight, with many also managing diabetes, heart, or kidney disease in a complex web of cardio-kidney-metabolic connections. Read our latest article to see how science is fighting back, with hormones like GLP-1 and amylin playing a leading role in our growing understanding and potential innovative management strategies: https://learn.az/6041Nq649 #WhatScienceCanDo

The future of healthcare relies on clinical trials. They deliver numerous benefits – from scientific innovation, access to emerging therapies, and being an important tool for healthcare delivery. Learn more: https://learn.az/6041NUxAV #WhatScienceCanDo #ClinicalTrialsDay